Table 2.
Specimen | Specimen type | Cepheid® Xpress SARS-CoV-2 assay |
Cobas® Liat® SARS-CoV-2 & Influenza A/B assay | |
---|---|---|---|---|
E gene | N2 gene | |||
1 | Saliva | 25.0 | 28.3 | 23.5 |
2 | NPS | 16.9 | 19.2 | 15.4 |
3 | Saliva | 27.7 | 29.9 | 23.2 |
4 | NPS | 17.2 | 18.8 | 13.4 |
5 | Saliva | 20.3 | 21.8 | 16.0 |
6 | Saliva | 29.4 | 32.2 | 30.2 |
7 | Saliva | 18.2 | 20.6 | 16.4 |
8 | Saliva | 26.4 | 28.6 | 24.2 |
9 | Saliva | 17.4 | 19.9 | 15.9 |
10 | Saliva | 20.3 | 22.6 | 21.0 |
11 | Saliva | 0.0 | 40.6 | 33.5 |
12 | NPS | 35.9 | 39.2 | 29.4 |
13 | NPS | 33.4 | 38.2 | 34.6 |
14 | Saliva | 16.1 | 18.6 | 12.1 |
15 | Saliva | 20.1 | 21.8 | 17.8 |
16 | NPS | 20.3 | 22.7 | 19.7 |
17 | NPS | 23.7 | 25.9 | 20.1 |
18 | Saliva | 26.0 | 28.1 | 21.5 |
19 | Saliva | 27.4 | 30.2 | 32.9 |
20 | Saliva | 32.3 | 36.1 | 28.1 |
21 | Saliva | 28.3 | 30.5 | 36.6 |
22 | Saliva | 25.3 | 27.7 | 24.5 |
23 | Saliva | 24.6 | 27.7 | 24.4 |
24 | NPS | 20.2 | 22.3 | 17.8 |
25 | Saliva | 23.9 | 25.9 | 21.3 |
26 | Saliva | 24.9 | 27.2 | 22.8 |
27 | Saliva | 18.1 | 20.8 | 11.3 |
28 | Saliva | 26.2 | 28.5 | 22.8 |
29 | Saliva | 0.0 | 40.9 | 32.9 |
30 | Saliva | 18.3 | 20.5 | 18.5 |
31 | Saliva | 27.9 | 30.6 | 25.5 |
32 | Saliva | 29.4 | 32.3 | 27.1 |
33 | Saliva | 20.8 | 22.9 | 15.8 |
34 | Saliva | 22.6 | 25.2 | 18.9 |
NPS: nasopharyngeal swab.